Mandatory Notification of Trade - Additional information warrants
(Oslo, Norway, 29 September 2016) Reference is made to the announcement on 14 September 2016 regarding the Rights Offering in Bionor Pharma ASA (the “Company”).
STOCK EXCHANGE ANNOUNCEMENT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES
In addition to information given in the announcement on Tuesday 27 September 2016 Cecilie Grue, a primary insider of the Company, owns 105,600 warrants through her wholly owned company Grue Invest AS.
In addition to information given in the announcement on Thursday 29 September 2016 Jens Krøis, a primary insider of the Company, owns 105,600 warrants.
Following the subscription of shares in the Rights Offering Jens Krøis and Cecilie Grue holds the following interests in the Company:
|Name||Position||Shares||Warrants||Subscription Rights in the Rights Issue|
|Director of legal affairs||270,762||105,600||0|
Unni Hjelmaas, Acting CEO, +47 915 19 651, firstname.lastname@example.org
Jens Krøis, CFO, +45 208 01 668, email@example.com
Link to announcement in pdf